Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines

Biochemical Pharmacology

Volumn 71, Issue 12, 2006, Pages 1695-1704

  Huang, Rong ^a   Murry, Daryl J ^b   Kolwankar, Dhanashri ^c   Hall, Stephen D ^c   Foster, David R ^a  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ABCB1; ABCC1; ABCC2; ABCC3; Transcriptional regulation; Vincristine

Indexed keywords

GLUCOCORTICOID RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; PREGNANE X RECEPTOR; RIFAMPICIN; VINCRISTINE;

ARTICLE; CARCINOMA CELL; CELL STRAIN CACO 2; CONTROLLED STUDY; EVALUATION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTESTINE CELL; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VINCRISTINE;

EID: 33646497418     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.03.009     Document Type: Article

References (18)

1. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2 1 (2002) 48-58
2. Kool M., de Haas M., Scheffer G.L., Scheper R.J., van Eijk M.J., Juijn J.A., et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57 (1997) 3537-3547
3. Minemura M., Tanimura H., and Tabor E. Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines. Int J Oncol 15 (1999) 559-563
4. Young L.C., Campling B.G., Cole S.P.C., Deeley R.G., and Gerlach J.H. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res 7 6 (2001) 1798-1804
5. van Tellingen O., Buckle T., Jonker J., Valk Mvd, and Beijnen J. P-glycoprotein and mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo. Br J Cancer 89 (2003) 1776-1782
6. Borst P., Evers R., Kool M., and Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92 16 (2000) 1295-1302
7. Gruol D.J., King M.N., and Kuehne M.E. Evidence for the locations of distinct steroid and vinca alkaloid interaction domains within the murine mdr1b P-glycoprotein. Mol Pharmacol 62 5 (2002) 1238-1248
8. Van Aubel R.A.M.H., Koenderink J.B., Peters J.G.P., Van Os C.H., and Russel F.G.M. Mechanisms and interaction of vinblastine and reduced glutathione transport in membrane vesicles by the rabbit multidrug resistance protein Mrp2 expressed in insect cells. Mol Pharmacol 56 4 (1999) 714-719
9. Giessmann T., Modess C., Hecker U., Zschiesche M., Dazert P., Kunert-Keil C., et al. CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects. Clin Pharmacol Ther 75 3 (2004) 213-222
10. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-delta delta CT method. Methods 25 (2001) 402-408
11. Sethi V.S., and Kimball J.C. Pharmacokinetics of vincristine sulfate in children. Cancer Chemother Pharmacol 6 (1981) 111-115
12. Geick A., Eichelbaum M., and Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276 18 (2001) 14581-14587
13. Asghar A., Gorski J.C., Haehner-daniels B., and Hall S.D. Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. Drug Metab Dispos 30 (2002) 20-26
14. Fromm M.F., Kauffmann H.-M., Fritz P., Burk O., Kroemer H.K., Warzok R.W., et al. The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol 157 5 (2000) 1575-1580
15. Synold T.W., Dussault I., and Forman B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7 5 (2001) 584-590
16. Kast H.R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., et al. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277 4 (2002) 2908-2915
17. Maglich J.M., Stoltz C.M., Goodwin B., Hawkins-Brown D., Moore J.T., and Kliewer S.A. Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62 3 (2002) 638-646
18. Staudinger J.L., Madan A., Carol K.M., and Parkinson A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metab Dispos 31 5 (2003) 523-527